Mizuho analyst Christopher Parkinson maintains Linde (NYSE:LIN) with a Neutral and raises the price target from $344 to $346.
Barclays Maintains Overweight on Danaher, Raises Price Target to $290
Barclays analyst Luke Sergott maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $277 to $290.